Introduction {#sec1-1}
============

*Listeria monocytogenes* is a Gram-positive zoonotic pathogen, responsible for listeriosis ([@B20]; [@B47]). The pathogen is ubiquitous in the environment, and has been detected in water and soil as well as animal feces. Cross-contamination of carcasses can occur in slaughterhouses or meat processing plants, resulting in transmission to consumers, and it causes fatal illness, especially in the susceptible populations such as the elderly, pregnant women, and fetuses ([@B49]). To treat listeriosis patients, ampicillin, gentamycin, or streptomycin are primarily used, but the resistance of *L. monocytogenes* has been increased to the antibiotics used for therapeutic purposes in human ([@B21]).

[@B42] investigated the prevalence of *L. monocytogenes* in swine carcasses in Italy from 2008 to 2011, and they reported that 33% of swine carcasses were *L. monocytogenes* positive with only two serotypes (1/2a and 1/2c). [@B34] investigated *L. monocytogenes* contamination in beef carcasses in the Republic of Ireland from July 2007 to June 2009, and reported that 27% of bovine hide and 14% of pre-chill carcasses were contaminated with *L. monocytogenes*, and the most commonly isolated serotype groups were 1/2a and 4b. In the US, the prevalence of *L. monocytogenes* in cattle carcasses was 0%--23.2% depending on slaughterhouse and season ([@B23]).

*L. monocytogenes* outbreaks in the US have recently been linked to consumption of packaged salad, soft cheese and cantaloupes, and the pathogen caused 292 deaths or fetal losses from 2009 to 2011, with a mortality rate of approximately 21% ([@B8]; [@B9]). In the EU member states, *L. monocytogenes* outbreaks were linked to the intake of ready-to-eat meat and poultry, cheese and fishery products ([@B18]). In 2011, 0.32 cases per 10,000 individuals were reported in the EU member states ([@B17]; [@B19]). In Japan, the first *L. monocytogenes* outbreak was reported in 2001, caused by consumption of contaminated cheese ([@B40]). The incidence rate in Japan was estimated to be 0.65 cases per million (83 cases per year), which is lower than that in the US and EU member states ([@B46]). In Korea, *L. monocytogenes* is considered not threatening human because there are no reported *L. monocytogenes* outbreaks. However, *L. monocytogenes* has been isolated from various foods such as sausages, smoked duck, and smoked salmon in Korea. In addition, the statistics of [@B26] showed that the number of listeriosis cases has increased from 16 in 2012 to 33 in 2014. These results indicate that there should be serious attention on *L. monocytogenes* in Korea.

The antibiotics consumption through self-prescription by farmers for prevention and treatment of animal disease increased by 25% from 2003 to 2012 ([@B38]). Since then, many studies reported the higher prevalence of antibiotic resistant *Escherichia coli, Salmonella* spp., *Campylobacter* spp. and *Staphylococcus aureus* in Korea ([@B10]; [@B39]; [@B38]; [@B35]). Although *L. monocytogenes* rarely acquired antibiotic resistance, the first antibiotic resistant *L. monocytogenes* was found in 1988 ([@B2]), and recent studies reported the antibiotic resistances of *L. monocytogenes* to ampicillin, amoxicillin, gentamicin, chloramphenicol, erythromycin, tetracycline, and vancomycin ([@B11]; [@B16]; [@B48]; [@B56]). However, there are only limited Korean studies on the prevalence of antibiotic resistant *L. monocytogenes*.

The objective of this study was to investigate the prevalence of *L. monocytogenes* in slaughterhouses and to determine serotype, genetic correlations, and antibiotic resistances of *L. monocytogenes* isolated from slaughterhouses and humans in Korea.

Materials and Methods {#sec1-2}
=====================

Sample collection {#sec2-1}
-----------------

Samples were collected from nine slaughterhouses (four in central area, three in southeastern area, and two in southwestern area) in Korea. In each slaughterhouse, three swine farms and three cattle farms were randomly selected, and three carcasses from each farm were randomly selected for sampling. After evisceration, fecal samples (n=136) were collected aseptically by cutting the cecum with a sterile scalpel, and these samples were placed in plastic vials. To obtain carcass samples (n=140) which were identical carcasses for collected fecal samples, 10 cm×10 cm sections of the rump areas of carcasses were swabbed with sterile gauze pads rehydrated with 40 mL buffered peptone water (BPW; Becton, Dickinson and Company, Sparks, MD, USA). Fourteen samples of the water used to wash the carcass were collected in conical tubes as environment samples. All slaughterhouse samples were stored at cold temperature until analyzed. In addition, 11 human isolates of *L. monocytogenes* were obtained from hospitals and the Korean Centers for Disease Control and Prevention.

*L. monocytogenes* isolation {#sec2-2}
----------------------------

Carcass samples were homogenized with 50 mL *Listeria* enrichment broth (LEB; Becton, Dickinson and Company) in a pummeler (BagMixer^®^ 400, Interscience, Saint Nom, France). The homogenates, fecal (25 g) and water (10 mL) samples in 50 mL LEB were enriched at 30°C for 24 h. For secondary enrichment, 1 mL aliquot of the primary enrichment were inoculated in 9 mL Fraser broth (Becton Dickinson and Company) supplemented with Fraser broth supplement (Becton, Dickinson and Company) and incubated at 37°C for 24--48 h. A loopful aliquot of the secondary enrichments was streaked on a Palcam agar (Becton, Dickinson and Company), followed by incubation at 30°C for 48 h. Presumptive *L. monocytogenes* colonies on the Palcam agar plates were inoculated in 10 mL tryptic soy broth plus 0.6% yeast extract (TSBYE; Becton, Dickinson and Company), followed by incubation at 30°C for 48 h.

A loopful aliquot of the cultures was then streaked on brain-heart infusion (BHI) agar (Becton, Dickinson and Company) and incubated at 30°C for 24 h. The isolated colonies on the plates were identified by polymerase chain reaction (PCR) analysis with *prs* (specific for *Listeria* spp.) primers \[F (5' GCTGAAGAGATTGCGAAAGAAG 3') and R (5' CAAAGAAACCTTGGATTTGCGG 3')\] ([@B15]) and *hly*A (specific for *L. monocytogenes*) primers \[F (5'CCT AAC ATA TCC AGG TGC TCT C 3') and R (5' CTG ATT GCG CCG AAG TTT AC 3')\] ([@B4]). PCR amplification was conducted using Phire Hot Start II DNA Polymerase Kit (Thermo Fisher, Waltham, MA, US) and performed by Rotor-Gene Q (Qiagen, Hilden, Germany). After an initial stage of 98°C for 30 sec, 35 cycles were performed with denaturation at 98°C for 5 sec, annealing at 60°C for 5 sec, and extension at 72°C for 10 sec. A final 1-min extension was performed at 72°C.

The *hly*A-positive samples were further-analyzed by 16S rRNA sequencing to identify *L. monocytogenes*. The primers 27F (5\' AGA GTT TGA TCM TGG CTC AG 3\') and 1492R (5\' TAC GGY TAC CTT GTT ACG ACT T 3\') were used for the 16S rRNA sequencing PCR ([@B36]; [@B53]). The PCR reaction was performed with 20 ng genomic DNA as the template in a 30-μL reaction mixture by using EF-Taq (Solgent, Daejeon, Korea). Activation of Taq polymerase was performed at 95°C for 2 min, followed by 35 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min and a final stage of 72°C for 10 min. The amplified products were purified with a multiscreen filter plate (Millipore Corp., Bedford, MA, USA). The DNA samples containing the extension products were added to Hi-Di formamide (Applied Biosystems, Foster City, CA, USA); the mixture was incubated at 95°C for 5 min and on ice for 5 min, and then analyzed using a ABI Prism 3730XL DNA analyzer (Applied Biosystems).

Polymerase chain reaction (PCR) analysis of virulence factors {#sec2-3}
-------------------------------------------------------------

Five virulence genes (*act*A, *inl*A, *inl*B, *plc*B, and *hly*A) were detected in isolated colonies from Palcam agar plates, using PCR analysis with the primers listed in [Table 1](#T1){ref-type="table"}. The colonies in Palcam agar plates were suspended in 50 μL of 0.05N NaOH (Samchun, Gyeonggi, Korea) with 0.25% sodium dodecyl sulfate (SDS). One hundred microliters of sterile dH~2~O were added to the suspension, which was incubated at 99°C for 15 min. For PCR amplification, this mixture (2 μL) was mixed with Phire Hot Start II DNA Polymerase Kit (Thermo Fisher), mixed Taq DNA polymerase (20 mM Tris-HCl, pH 7.4 at 25°C; 0.1 mM EDTA; 1 mM DTT; 100 mM KCl; 200 μg/mL BSA; and 50% glycerol), 1× reaction buffer \[1.5 mM MgCl~2~, 200 μM deoxynucleoside triphosphates (dNTP; Promega Corporation, Madison, USA)\], and 0.5 μM each primer. PCR was performed by Rotor-Gene Q (Qiagen) with initial denaturation at 98°C for 30 sec, followed by 35 cycles of 98°C for 5 sec, 60°C for 5 sec, and 72°C for 10 sec and a final extension at 72°C for 1 min. Twenty microliters of reaction PCR products were mixed with 4 μL loading star (Dyne Bio, Gyeonggi, Korea), followed by electrophoresis analysis with a 1.5% agarose gel.

###### Primers used for PCR amplification of virulence genes from *Listeria monocytogenes* isolates

  -------------------------------------------------------------
  Primer   Size (bp)   Sequence (5´ to 3´)          Reference
  -------- ----------- ---------------------------- -----------
  *inl*A   255         F : CCTAGCAGGTCTAACCGCAC\    [@B41]
                       R : TCGCTAATTTGGTTATGCCC     

  *inl*B   146         F : AAAGCACGATTTCATGGGAG\    [@B14]
                       R : ACATAGCCTTGTTTGGTCGG     

  *hly*A   174         F : GCATCTGCATTCAATAAAGA\    [@B54]
                       R : TGTCACTGCATCTCCGTGGT     

  *act*A   268(385)    F : GACGAAAATCCCGAAGTGAA\    [@B32]
                       R : CTAGCGAAGGTGCTGTTTCC     

  *plc*B   261         F : GGGAAATTTGACACAGCGTT\    [@B14]
                       R : ATTTTCGAAGGTAGTCCGCTTT   
  -------------------------------------------------------------

PCR, Polymerase chain reaction.

*L. monocytogenes* serotyping {#sec2-4}
-----------------------------

Serotypes for *L. monocytogenes* isolates were determined by both agglutination and multiplex-PCR analysis. Common results for serotypes from both analyses were used as the serotypes for the isolates. For agglutination analysis, *Listeria* antisera (Denka Seiken, Tokyo, Japan) were used to identify O antigen and H antigen according to the manufacturer's instruction. Multiplex-PCR analysis was performed according to the previous methods with *lmo*0737, *lmo*1118, ORF2819, ORF2110, and *prs* gene target primers ([@B15]). Amplification reactions for all isolates were performed using the Qiagen multiplex PCR kit (Qiagen) in Rotor-Gene Q with pre-incubation at 94°C for 15 min, followed by 35 cycles at 94°C for 30 sec, 57°C for 90 sec, and 72°C for 60 sec and terminal elongation at 60°C for 30 min. The final multiplex PCR products mixed with loading star were resolved on 1.5% agarose within 1× TAE buffer for 20 min. Subsequently, the serotypes of *L. monocytogenes* were determined by multiplex PCR amplification patterns.

Pulsed-field gel electrophoresis {#sec2-5}
--------------------------------

*L. monocytogenes* isolates were analyzed using pulsed-field gel electrophoresis (PFGE) according to the standard protocol by [@B22] with some modifications. *L. monocytogenes* cultures were embedded in 1% SeaKem gold agarose (Cambrex, NJ, USA) and lysed with cell lysis buffer (50 mM Tris, 50 mM EDTA, 1% Sarcosine) and proteinase K for 2 h at 54--55°C. Molds of the samples were washed with TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) for seven times, followed by digestion with restriction enzyme *Asc*I (Enzynomics, Korea) at 37°C for 2 h. Size separation of restricted DNA fragments was performed in 0.5× Tris Borate EDTA (TBE) by using a CHEF MAPPER XA system (Bio-Rad, Richmond, CA, USA) with 1% SeaKem gold agarose gel at 14°C and 6.0 V/cm angle of 120° with a linear ramping factor of 2.2--54 sec for 19 h. *Xba*I-digested *Salmonella* *enterica*-serotype Braenderup H9812 DNA was used as a standard to compare each band of *L. monocytogenes* isolates. After electrophoresis, the agarose gel was stained with SYBR gold (Molecular Probes, Eugene, USA) and destained with dH~2~O for 1 h. Pattern images were captured using an LAS-3000 imaging system (Fujifilm, Japan), and PFGE patterns were analyzed using Gelcompar II 6.6 software (Applied Maths, Sint-Matins-Latem, Belgium). Similarity clustering analyses of all isolates were performed by UPGMA (unweighted pair group method with arithmetic mean) with Dice correlation coefficient and 1% tolerance.

Antibiotic resistance analysis {#sec2-6}
------------------------------

Antibiotic disc diffusion test was performed according to Clinical Laboratory Standards Institute procedure to evaluate antibiotic resistances ([@B12]). A single isolated colony of *L. monocytogenes* was transferred into 10 mL TSBYE, incubated at 30°C for 24 h. After the incubation, the culture was diluted with 5 mL phosphate buffered saline (PBS, pH 7.4; KH~2~PO~4~, 0.2 g; Na~2~HPO~4~, 1.5 g; NaCl, 8.0 g; KCl, 0.2 g in 1 L of dH~2~O) to a turbidity equivalent to 0.2 at OD~620~ (approximately 10^8^ CFU/mL). Sterile swab was dampened with the diluent, and spread onto the surface of a Muller-Hinton agar plate (MHA; Becton, Dickinson and Company). The MHA plates were dried at room temperature for 10 min to allow adsorption of the liquid. Antibiotic discs (Oxoid, Basingstoke, UK) were then placed on the surface of the MHA plates. The 12 antibiotics (amounts) were examined as following; gentamycin (10 μg), penicillin G (10 units), tetracycline (30 μg), spectinomycin (100 μg), kanamycin (30 μg), erythromycin (15 μg), tigecycline (15 μg), ampicillin (10 μg), streptomycin (10 μg), vancomycin (30 μg), chloramphenicol (30 μg), and rifampicin (5 μg) (Oxoid). After incubation at 30°C for 24 h, the diameters of the clear zones were measured and sensitivities (susceptible, intermediates, and resistance) were determined according to the standards of the Clinical Laboratory Standard Institute ([@B12]).

Results {#sec1-3}
=======

Prevalence of *L. monocytogenes* {#sec2-7}
--------------------------------

Fifteen samples (5.17%) of 290 samples such as carcasses, feces, and water samples from nine slaughterhouses were *L. monocytogenes* positive. The pathogen was isolated only from carcass samples, and not from fecal or water samples. Of 140 carcass samples, 15 samples (10.71%) were contaminated with the pathogen, which could be considered high prevalence ([Table 2](#T2){ref-type="table"}). *L. monocytogenes* was isolated from six (66.7%) of nine slaughterhouses (data not shown). Of 75 swine carcass samples, 11 samples (14.7%) were contaminated with *L. monocytogenes*, and four (6.6%) of 61 cattle carcass samples were contaminated with the pathogen (data not shown), indicating that the swine carcasses were more frequently contaminated with the pathogen than cattle carcasses in Korea.

###### Prevalence of *Listeria monocytogenes* in the slaughterhouse

  Slaughterhouse   Sample   Total (%)              
  ---------------- -------- --------------- ------ --------------
  Central 1        0/18     5/18(27.78)     0/1    5/37(13.51)
  Central 2        0/18     1/18(5.56)      0/2    1/38(2.63)
  Central 3        0/18     2/18(11.11)     0/2    2/38(5.26)
  Central 4        0/3      0/6             0      0/9
  South west 1     0/18     4/18(22.22)     0/2    4/38(10.53)
  South west 2     0/18     1/19(5.26)      0/2    1/39(2.56)
  South east 1     0/15     2/15(13.33)     0/2    2/32(6.25)
  South east 2     0/19     0/19            0/2    0/40
  South east 3     0/9      0/9             0/1    0/19
  Total            0/136    15/140(10.71)   0/14   15/290(5.17)

Serotypes of *L. monocytogenes* isolates {#sec2-8}
----------------------------------------

Fifteen isolates from carcasses and 11 human isolates obtained from hospitals and KCDC in Korea were further analyzed for serotypes by multiplex PCR and agglutination assay. Multiplex PCR analysis classified *L. monocytogenes* isolates into four groups. Group 1 (1/2a and 3a), Group 2 (1/2c and 3c), Group 3 (1/2b, 3b, and 7), and Group 4 (4b, 4d, and 4e) of serovars as determined by lineage-specific and serogroup-specific sequences for *L. monocytogenes* strains according to the method by [@B15]. This method identified several serotypes rather than one serotype, and thus, an agglutination assay was necessary; however, the result of agglutination assay could be affected by researcher subjectivity. Therefore, common serotypes identified in both methods were considered the serotypes of the isolate. The results showed that the human isolates were three 1/2b isolates (27.3%), three 4b isolates (27.3%), and two 1/2a isolates (18.2%) ([Table 3](#T3){ref-type="table"}), which are known to be the most common serotypes for foodborne disease ([@B1]). While slaughterhouse isolates were five 1/2a isolates (33.3%), seven 1/2b isolates (46.7%), and three 1/2c isolates (20%) from cattle and swine carcasses ([Table 4](#T4){ref-type="table"}). These results indicate that serotypes between slaughterhouse and human isolates are similar, and most strains were foodborne disease-related serotypes.

###### Serotypes and information of *Listeria monocytogenes* isolates from humans

  Strains      Sources                                     Serotype
  ------------ ------------------------------------------- ----------
  SMFM-CI-1    Male, 18 year-old                           4b
  SMFM-CI-2    Human, blood, 1/2a                          1/2a
  SMFM-CI-3    Female, blood, 82 year-old                  1/2b
  SMFM-CI-4    Female, blood, 72 year-old                  1/2b
  SMFM-CI-5    Male, blood, 67 year-old                    3b
  SMFM-CI-6    Male, blood, 71 year-old                    1/2b
  SMFM-CI-7    Male, blood, 73 year-old                    1/2a
  SMFM-CI-8    Male, stomach cancer, 66 year-old           1/2c
  SMFM-CI-9    Female, bacterial meningitis, 61 year-old   4d
  SMFM-CI-10   Male, bacterial meningitis, 78 year-old     4b
  SMFM-CI-11   Female, hepatic abscess, 81 year-old        4b

###### Serotypes and information of *Listeria monocytogenes* isolates from carcasses

  Strains      Sampling location^[1)](#table1-tfn1){ref-type="table-fn"}^   Animal   Serotype
  ------------ ------------------------------------------------------------ -------- ----------
  SMFM-SI-1    A                                                            Swine    1/2b
  SMFM-SI-2    A                                                            Swine    1/2b
  SMFM-SI-3    A                                                            Swine    1/2b
  SMFM-SI-4    A                                                            Swine    1/2b
  SMFM-SI-5    A                                                            Swine    1/2b
  SMFM-SI-6    E                                                            Cattle   1/2a
  SMFM-SI-7    E                                                            Cattle   1/2c
  SMFM-SI-8    E                                                            Cattle   1/2c
  SMFM-SI-9    E                                                            Cattle   1/2c
  SMFM-SI-10   B                                                            Cattle   1/2a
  SMFM-SI-11   C                                                            Swine    1/2a
  SMFM-SI-12   C                                                            Swine    1/2a
  SMFM-SI-13   D                                                            Swine    1/2b
  SMFM-SI-14   D                                                            Swine    1/2b
  SMFM-SI-15   F                                                            Swine    1/2a

^1)^ A, slaughterhouse-1 in central area; B, slaughterhouse-2 in central area; C, slaughterhouse-3 in central area; D, slaughterhouse-1 in south west area; E, slaughterhouse-1 in south west area; F, slaughterhouse-2 in south west area.

Virulence characterization of *L. monocytogenes* {#sec2-9}
------------------------------------------------

Five virulence genes (*act*A, *inl*A, *inl*B, *hly*A, and *plc*B) were observed for *L. monocytogenes* slaughterhouse and human isolates, except for *inl*B in *L. monocytogenes* SMFM-SI-15 ([Fig. 1](#F1){ref-type="fig"}). The strain did not contain *inl*B, which is involved in mediating invasion into mammalian cells ([@B7]). Interestingly, 10 of 11 human isolates (90.9%) had a 268-bp amplicon of *act*A, but most of 15 slaughterhouse isolates (86.7%) had a 385-bp amplicon of *act*A ([Fig. 2](#F2){ref-type="fig"}).

![PCR amplification of *Inl*B from *Listeria monocytogenes* isolates (SI) obtained from carcasses.\
PCR amplification showed that *L. monocytogenes* isolate SI-15 has no *inl*B, which plays a role in invasion.](kosfa-38-5-851-g1){#F1}

![PCR amplification of *act*A from *Listeria monocytogenes* isolates obtained from humans (A; CI) and carcasses (B; SI).\
*Act*A gene showed generally different size of base pair between slaughterhouse and human isolates. 90.9% of human isolates had 268 bp size of *act*A, and 86.7% of slaughterhouse isolates had 385 bp.](kosfa-38-5-851-g2){#F2}

PFGE genotype of *L. monocytogenes* isolates {#sec2-10}
--------------------------------------------

Twenty-six *L. monocytogenes* slaughterhouse and human isolates were genotyped using PFGE ([Fig. 3](#F3){ref-type="fig"}). The application of DNA macro restriction with *Asc*I revealed major four groups with 70% similarity and 12 clusters with 90% similarity. All *L. monocytogenes* isolates could be divided into two major patterns at approximately 55.3% similarity, which were serotyped as 1/2a and 1/2c (59.3% similarity between groups) and 1/2b-4 (64.7% similarity). Group 1 (more than 80.4 % similarity) included five isolates of serotype 1/2c (n=4) and 1/2a. Group 2 included five isolates of serotype 1/2a; *L. monocytogenes* SMFM-CI-2 human isolate had 93.3 % similarity with *L. monocytogenes* strains SMFM-SI-6 (south west 1-swine) and SMFM-SI-10 (central 2-cattle). Group 3 included 11 isolates of serotype 1/2b (n=10) and 3b (n=1), which were divided into clusters based on *act*A size and geographical characterization. In Group 3, although isolation sources were different, the carcass isolates (*L. monocytogenes* strains SMFM-SI-13 and SMFM-SI-14) containing 268-bp *act*A showed more similarity (81.2%) with human isolates containing 268-bp *act*A, than carcass isolates (77.7%) with 385-bp *act*A. Group 4 contained serotype 4b and 4d isolates. Some *L. monocytogenes* isolates shared 100% similarity isolates from different locations.

![PFGE patterns observed for *Listeria monocytogenes* isolates from carcasses and humans.\
Dendrogram (UPGMA clustering based on the Dice correlation coefficient) of *L. monocytogenes* *Asc*I PFGE patterns for 26 clinical and slaughterhouse isolates. Region 1: central area, Region 2: south west area, Region, 3: south east area. PFGE, pulsed-field gel electrophoresis; UPGMA, unweighted pair group method with arithmetic mean.](kosfa-38-5-851-g3){#F3}

Antibiotic resistance {#sec2-11}
---------------------

All fifteen *L. monocytogenes* strains isolated from slaughterhouses were susceptible to the antibiotics, including gentamicin, bacitracin, spectinomycin, kanamycin, erythromycin, tigecycline, vancomycin, chloramphenicol, and rifampicin. However, the resistance rates of the isolates to penicillin G, tetracycline, ampicillin, and streptomycin resistances were 93.3%, 20%, 26.7%, and 60%, respectively ([Table 5](#T5){ref-type="table"}). *L. monocytogenes* strains SMFM-SI-13 and SMFM-SI-14 exhibited multiple resistances to four antibiotics such as tetracycline, penicillin, ampicillin, and streptomycin. *L. monocytogenes* SMFM-SI-12 also showed multiple resistance to penicillin G, ampicillin, and streptomycin. *L. monocytogenes* strains SMFM-SI-1, SMFM-SI-5, and SMFM-SI-15 had resistance only penicillin G, *L. monocytogenes* SMFM-SI-11 had resistance to streptomycin, and *L. monocytogenes* SMFM-SI-8 had no resistance for used antibiotics in this study. In clinical isolates, all 11 *L. monocytogenes* strains isolated from clinical patients were susceptible to the antibiotics such as gentamycin, spectinomycin, kanamycin, tigecycline, and chloramphenicol ([Table 6](#T6){ref-type="table"}). Six *L. monocytogenes* isolates (54.5%) from clinical patients had resistance more than three antibiotics, especially, two *L. monocytogenes* isolates (*L. monocytogenes* strains SMFM-CI-4 and SMFM-CI-7) showed multiple resistances to six antibiotics such as bacitracin, penicillin G, erythromycin, ampicillin, streptomycin, and rifampicin. These results indicate that clinical isolates had multiple antibiotic resistance more than the isolates from slaughterhouses.

###### Antibiotic sensitivity of *Listeria monocytogenes* strains isolated from slaughterhouses (n=15)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Antibiotics        Strains isolated from slaughterhouse   Sensitivity of the isolates (n, %) ^1)^                                                                                                                                        
  ------------------ -------------------------------------- ----------------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- ------ -------- -------- -------- -------- -------- --------
  Gentamycin         S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Bacitracin         S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Penicillin G       R                                      R                                         R        R        R        R        R        S        R        R        R        R      R        R        R        1\                14\
                                                                                                                                                                                                                         (6.7)             (93.3)

  Tetracycline       S                                      S                                         S        S        S        S        S        S        R        S        S        S      R        R        S        12\               3\
                                                                                                                                                                                                                         (80)              (20)

  Spectinomycin      S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Kanamycin          S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Erythro-mycin      S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Tigecycline        S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Ampicillin         S                                      I                                         I        S        S        I        S        S        S        R        S        R      R        R        I        7\       4\       4\
                                                                                                                                                                                                                         (46.6)   (26.7)   (26.7)

  Strepto-mycin      I                                      R                                         R        R        I        R        R        I        I        I        R        R      R        R        I                 6\       9\
                                                                                                                                                                                                                                  (40)     (60)

  Chloram-phenicol   S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Rifampicin         S                                      S                                         S        S        S        S        S        S        S        S        S        S      S        S        S        15\               
                                                                                                                                                                                                                         (100)             

  Susceptible\       10\                                    9\                                        9\       10\      10\      9\       10\      11\      9\       9\       11\      9\     8\       8\       9\                         
  (n, %)             (83.3)                                 (75)                                      (75)     (83.3)   (83.3)   (75)     (83.3)   (91.7)   (75)     (75)     (91.7)   (75)   (66.7)   (66.7)   (75)                       

  Intermediate\      1\                                     1\                                        1\       0        1\       1\       0        1\       1\       1\       0        0      0        0        2\                         
  (n, %)             (8.3)                                  (8.3)                                     (8.3)             (8.3)    (8.3)             (8.3)    (8.3)    (8.3)                                      (16.7)                     

  Resistant\         1\                                     2\                                        2\       2\       1\       2\       2\       0        2\       2\       1\       3\     4\       4\       1\                         
  (n, %)             (8.3)                                  (16.7)                                    (16.7)   (16.7)   (8.3)    (16.7)   (16.7)            (16.7)   (16.7)   (8.3)    (25)   (33.3)   (33.3)   (8.3)                      
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

According to CLSI guidelines using the breakpoints of *Staphylococcus* species resistance because no resistance criteria exist for *Listeria* susceptibility testing in the CLSI guidelines ([@B5]).

###### Antibiotic sensitivity of *Listeria monocytogenes* strains obtained from human (n=11)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Antibiotics       Strains obtained from human   Sensitivity of the isolates (n, %)^[1)](#table6-tfn1){ref-type="table-fn"}^                                                                                                     
  ----------------- ----------------------------- ----------------------------------------------------------------------------- ------ ------ ------ ------ ------ -------- -------- -------- -------- -------- -------- -------- --
  Gentamycin        S                             S                                                                             S      S      S      S      S      S        S        S        S        11\                        
                                                                                                                                                                                                       (100)                      

  Bacitracin        S                             R                                                                             S      R      S      S      R      S        S        S        S        8\                3\       
                                                                                                                                                                                                       (72.7)            (27.3)   

  Penicillin G      R                             R                                                                             R      R      R      R      R      R        R        R        R                          11\      
                                                                                                                                                                                                                         (100)    

  Tetracycline      S                             S                                                                             R      S      R      R      S      S        S        S        S        8\                3\       
                                                                                                                                                                                                       (72.7)            (27.3)   

  Spectinomycin     S                             S                                                                             S      S      S      S      S      S        S        S        S        11\                        
                                                                                                                                                                                                       (100)                      

  Kanamycin         S                             S                                                                             S      S      S      S      S      S        S        S        S        11\                        
                                                                                                                                                                                                       (100)                      

  Erythromycin      S                             I                                                                             S      R      S      S      R      S        S        S        S        8\       1\       2\       
                                                                                                                                                                                                       (72.7)   (9.1)    (18.2)   

  Tigecycline       S                             S                                                                             S      S      S      S      S      S        S        S        S        11\                        
                                                                                                                                                                                                       (100)                      

  Ampicillin        S                             R                                                                             S      R      S      S      R      S        S        S        S        8\                3\       
                                                                                                                                                                                                       (72.7)            (27.3)   

  Streptomycin      I                             R                                                                             R      R      R      R      R      S        R        I        I        1\       3\       7\       
                                                                                                                                                                                                       (9.1)    (27.3)   (63.6)   

  Chloramphenicol   S                             S                                                                             S      S      S      S      S      S        S        S        S        11\                        
                                                                                                                                                                                                       (100)                      

  Rifampicin        S                             R                                                                             S      R      S      S      R      S        S        S        S        8\                3\       
                                                                                                                                                                                                       (72.7)            (27.3)   

  Susceptible\      10\                           6\                                                                            9\     6\     9\     9\     6\     11\      10\      10\      10\                                 
  (n, %)            (83.3)                        (50)                                                                          (75)   (50)   (75)   (75)   (50)   (91.7)   (83.3)   (83.3)   (83.3)                              

  Intermediate\     1\                            1\                                                                                                                                 1\       1\                                  
  (n, %)            (8.3)                         (8.3)                                                                                                                              (8.3)    (8.3)                               

  Resistant\        1\                            5\                                                                            3\     6\     3\     3\     6\     1\       2\       1\       1\                                  
  (n, %)            (8.3)                         (41.7)                                                                        (25)   (50)   (25)   (25)   (50)   (8.3)    (16.7)   (8.3)    (8.3)                               
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1)^ According to CLSI guidelines using the breakpoints of *Staphylococcus* species resistance because no resistance criteria exist for *Listeria* susceptibility testing in the CLSI guidelines ([@B5]).

Discussion {#sec1-4}
==========

Although only a few cases of *L. monocytogenes* infection in humans are reported in Korea, it must be considered a major public health problem because of its ubiquitous distribution and presence in many animals, food products, raw materials, and environments. More information for the epidemiology, antibiotic resistant profiles and the genetic relationships of *L. monocytogenes* isolates from production chains would be helpful in understanding the cause of listeriosis and aspect of *L. monocytogenes* antibiotic resistance, and determining an appropriate approach for prevention of contamination.

In this study, 290 samples of carcasses, feces, and washing water from nine slaughterhouses in Korea were collected. Fifteen *L. monocytogene*s isolates were obtained, only from carcasses, not from feces and water samples. It suggests that pathogens on the carcasses may be cross-contaminated by workers or physical contact between carcasses in a slaughterhouse rather than cross-contamination from feces. This result was supported by a study of Muhterem-[@B44], suggesting that *L. monocytogenes* can be cross-contaminated onto meat carcasses from cutting board and packaging rooms due to unhygienic evisceration equipment. Thus, in our study it can be also suggested that *L. monocytogenes* on the carcasses might be from unhygienic environments.

Notably, at least 95% of *L. monocytogenes* strains isolated from listeriosis patients belonged to serotypes 1/2a, 1/2b, and 4b ([@B33]). The most frequent *L. monocytogenes* serotypes in the carcasses were 1/2a and 1/2b (80%), followed by 1/2c (20%), which has low pathogenic potential but sporadically causes listeriosis in animals ([@B25]). This result indicates that *L. monocytogenes* serotypes 1/2a, 1/2b, and 4b are the most prevalent isolates in carcasses and humans in Korea, which are the predominant serotypes causing human infections are 1/2a, 1/2b, and 4b ([@B52]). In this study, most isolates harbored virulence genes (*act*A, *inl*A, *inl*B, *hly*A, and *plc*B), indicating that they are pathogenic. Ten of the 11 clinical *L. monocytogenes* isolates showed 268 bp size of *act*A, rather than 385 bp size of *act*A which was the size of the gene in most of the slaughterhouse isolates. [@B29] found that the low molecular mass of *act*A was due to a deletion in *act*A, and it is probably not in the amino-terminal region, which is essential for F-actin assembly and movement. The deletion likely occurred in the internal proline-rich regions or carboxy-terminal domain ([@B50]). [@B55] suggested that the length of *act*A is related to pathogenic properties. [@B24] reported that the invasion efficiency of *L. monocytogenes* strains with the 268 bp size of *act*A was 1--2.5 times lower than those of the strains with the 385 bp size of *act*A in healthy cells, but the invasion efficiency became similar in senescent cells. Thus, this *act*A size may be related to pathogenicity.

PFGE of the DNA of the 26 isolates digested with *Asc*I showed 7--16 fragments of approximately 30 to 1,130 kb ([@B45]). Generally, *Asc*I and *Apa*I are considered the most useful restriction enzymes for *Listeria* spp. ([@B27]; [@B31]). However, [@B6] reported that the DNA of many *Listeria* serovar 1/2c isolates was not digested by *Apa*I and *Not*I. Therefore, we chose *Asc*I as it is more efficient for serovar 1/2c and 4c ([@B3]; [@B30]). When the DI value quoted by Simpson's discriminatory index was calculated ([@B28]), twenty six *L. monocytogenes* isolates from our study had 0.93 of DI. The isolates were divided into four groups with at least 70% similarity, and the serogroups clustered according to their pulsotypes: 1/2c (Group 1), 1/2a (Group 2), 1/2b (Group 3), and 4 types (Group 4). At the 0.90--1.00 similarity level, some clusters were diverse according to geographical origins and isolation origins. Thus, the results of PFGE indicates that *L. monocytogenes* serotypes are genetically correlated, and *L. monocytogenes* can be cross-contamination between different geographical locations, which may be caused by collecting animals from different farms but slaughtering in same slaughterhouse.

Although many foodborne pathogens were concerned because of their antibiotic resistance, the antibiotic resistance of *L. monocytogenes* has not been issued yet. To treat listeriosis various antibiotics such as penicillin, vancomycin, erythromycin, tetracycline, and chloramphenicol are currently used ([@B48]). [@B2] reported that 7.1% *L. monocytogenes* strain isolate from animal food showed antibiotic resistance to streptomycin. In our study, the *L. monocytogenes* isolates showed the resistances to some of the therapeutic antibiotics such as for penicillin G (93.3%) and tetracycline (20%) isolated from slaughterhouses. Also, *L. monocytogenes* isolates from clinical patients have the resistances to penicillin G (100%) and streptomycin (63.6%). In addition, some isolates were multidrug resistant to more than three antibiotics. Twenty percent *L. monocytogenes* isolates from slaughterhouses and 54.5% isolates from clinical patients showed multidrug resistant. These results suggest that the antibiotic resistances of *L. monocytogenes* have been increased, especially to therapeutic antibiotics of listeriosis treatment for human, and thus, *L. monocytogenes* infection may cause worse pathological results than the past ([@B13]; [@B43]; [@B51]).

In conclusion, *L. monocytogenes* were isolated from carcasses in slaughterhouses in Korea, and the pathogens may be cross-contaminated in slaughterhouses. There were also human listeriosis patients, and the serotypes of the isolates from carcasses and humans were the one related to the foodborne illness such as 1/2a, 1/2b and 4b serotypes. In addition, the prevalence of multiantibiotic resistant *L. monocytogenes* was high, especially in human isolates. These results suggest that the risk of *L. monocytogenes* could be considered high in Korea. Therefore, intensive attention and control plans for *L. monocytogenes* are necessary.
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